Epizyme reported $17K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Amarin AMRN:US $ 294.66M 0.3M
Amgen AMGN:US $ 31343M 96M
Avrobio Inc AVRO:US $ 4K 0
Biogen BIIB:US $ 0.1M 0M
Bluebird Bio BLUE:US $ 0.74M 0.02M
Cerulean Pharma CERU:US $ 0.01M 0M
Daiichi Sankyo 4568:JP Y 50000M 0M
Eisai 4523:JP Y 44986M 0M
Epizyme EPZM:US $ 0.02M 0M
Exelixis EXEL:US $ 0.32M 0M
GlaxoSmithKline GSK:LN 1347M 0M
Glaxosmithkline GSK:US $ 1347M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Macrogenics MGNX:US $ 0.62M 0M
Mirati Therapeutics MRTX:US $ 0.06M 0M
Novartis NOVN:VX SF 890M 11M
Novartis NVS:US $ 890M 11M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
Spectrum Pharmaceuticals SPPI:US $ 0.18M 0.01M
Vertex Pharmaceuticals VRTX:US $ 2.6M 0M
Xencor XNCR:US $ 0.6M 0M